Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moinzadeh

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Zeitschrift Fur Rheumatologie|April 18, 2008
[Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)]N Hunzelmann, E Genth, T Krieg, et al.
The British Journal of Dermatology|February 3, 2009
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factorsC Sunderkötter, I Herrgott, C Brückner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 17, 2020
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsetsP Moinzadeh, P Frommolt, M Franitza, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
The British Journal of Dermatology|December 29, 2015
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesN Hunzelmann, G Riemekasten, M O Becker, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Rheumatology (Oxford, England)|June 3, 2008
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvementN Hunzelmann, E Genth, T Krieg, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Zeitschrift Fur Rheumatologie|April 18, 2008
[Organ-specific diagnosis in patients with systemic sclerosis: Recommendations of the German Network for Systemic Sclerosis (DNSS)]N Hunzelmann, E Genth, T Krieg, et al.
The British Journal of Dermatology|February 3, 2009
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factorsC Sunderkötter, I Herrgott, C Brückner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 17, 2020
Whole blood gene expression profiling distinguishes systemic sclerosis-overlap syndromes from other subsetsP Moinzadeh, P Frommolt, M Franitza, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
The British Journal of Dermatology|December 29, 2015
The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodiesN Hunzelmann, G Riemekasten, M O Becker, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Rheumatology (Oxford, England)|June 3, 2008
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvementN Hunzelmann, E Genth, T Krieg, et al.
Pageof 2